Trials / Completed
CompletedNCT04766385
Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis
A Phase 3, Open-label, Single-arm Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of KHK7791 by comparing changes in serum phosphorus levels from baseline values between peritoneal dialysis patients with hyperphosphatemia receiving repeated administration of KHK7791 for 8 weeks and those receiving placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK7791 | oral administration |
Timeline
- Start date
- 2021-03-03
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2021-02-23
- Last updated
- 2022-01-11
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04766385. Inclusion in this directory is not an endorsement.